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Abstract
We describe the case of a patient with ventricular pre-excitation who underwent dobutamine
stress echocardiography to evaluate atypical chest pain. The patient safely underwent the
procedure with interesting electrocardiographic findings during pharmacological stress. The
risks of dobutamine stress testing, along with possible explanations of this observed event, are
discussed. In conclusion, the safety of dobutamine stress testing in patients with ventricular
pre-excitation has not been established; further prospective studies are needed to decide whether
dobutamine stress testing is safe in certain subsets of this population. (Cardiol J 2011; 18, 4:
437–440)
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Introduction
Exercise stress testing may provide some in-
sight into the physiological behavior of the acces-
sory pathway in patients with Wolff-Parkinson-
-White (WPW) syndrome and it may estimate their
risk of sudden arrhythmic death, as abrupt (i.e. not
gradual) loss of pre-excitation may indicate that the
accessory pathway could not conduct rapidly dur-
ing atrial fibrillation (AF) [1]. However, the role of
pharmacological stress testing, specifically with do-
butamine, in arrhythmic risk stratification of pa-
tients with WPW, has not been described, nor has
the risk for developing an arrhythmia during such
testing been fully ascertained. A small study sug-
gested that dobutamine can facilitate anterograde
accessory pathway conduction, which could in-
crease the risk of ventricular fibrillation in patients
during testing if they were to go into AF [2]. A pa-
tient with ventricular pre-excitation who underwent
dobutamine stress echocardiography (DSE) at our
institution for evaluation of atypical chest pain has
provided an opportunity to discuss the risks of do-
butamine stress testing and whether the test might
predict sudden death in individuals with WPW.
Theoretically, inducing tachyarrhythmia by dobu-
tamine infusion could potentially be used for risk
stratification of asymptomatic patients with WPW.
However, it is unclear whether disappearance of the
pre-excitation delta wave during dobutamine infu-
sion carries the same prognostic significance as
when it occurs during exercise test. This important
question should be further investigated in a pro-
spective study.
Case report
A 44 year-old African American man with hy-
pertension, hyperlipidemia, prior alcohol abuse, and
a questionable previous myocardial infarction was
referred to our institution for further evoluation of
chest pain. He stated that the ‘knife-like’ pain be-
gan in the sub-xyphoid area and then moved around
his chest, and that it was associated with shortness
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of breath and arm numbness. Cardiac biomarkers
were normal and his electrocardiogram (ECG)
showed sinus rhythm with abnormal ST-T wave
changes. Given the atypical features of his history
and the ST-T wave changes, the managing team
elected to perform non-invasive testing. As it was
felt that the patient may not be able to achieve his
target heart rate with treadmill exercise, DSE was
ordered. This is preferred to adenosine or dipyrida-
mole radionuclinde pharmacological stress testing at
our institution. At baseline, the patient was in sinus
bradycardia (52 bpm) with obvious pre-excitation
and ST-T wave abnormalities, due at least in part
to his abnormal (pre-excited) depolarization se-
quence (Fig. 1). With dobutamine infusion, the pa-
tient achieved a heart rate of 150 bpm and deve-
loped premature ventricular contractions with 1 mm
ST depression in II, AVF, V5, and V6. Delta waves
gradually became smaller but were still present
(Fig. 2). In recovery (Fig. 3), with a heart rate of
81 bpm, the delta waves returned to their baseline
appearance, but non-diagnostic changes in the ST-T
waves persisted. Transthoracic echocardiography
revealed normal left ventricular size and function
at rest and no regional wall motion abnormalities
during dobutamine stress. The left ventricular ejec-
tion fraction increased from 55 to > 70%, with near
cavity obliteration and hyperdynamic contractility.
Figure 2. Peak stress ECG (note less obvious pre-excitation).
Figure 1. Baseline ECG prior to dobutamine stress echocardiography.
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During his hospitalization, the patient mentioned
that in addition to chest pain, he previously had
episodes of near-syncope and possible syncope. He
was therefore referred to the Electrophysiology
Service, and underwent successful accessory path-
way ablation. After discharge, the patient was seen
in the cardiology clinic about two months later. He
reported some chest pain symptoms, but denied any
syncopal episodes. There was sufficient concern to
admit the patient for further evaluation. However,
the patient did not want to be admitted at that time.
Discussion
Ventricular pre-excitation (short PR-interval
with delta waves) occurs when one or more acces-
sory pathways enable conduction from the atrium
to the ventricle to bypass the atrio-ventricular (AV)
node and activate a portion of the ventricle prema-
turely, widening and distorting the QRS complex.
The delta waves become larger as the amount of
pre-excited tissue increases. Patients with WPW
syndrome have both ventricular pre-excitation and
arrhythmias, which may be AF, AV re-entry, or
both. Patients with the WPW pattern have charac-
teristic ECG findings of pre-excitation but no sub-
jective or objective evidence of arrhythmia. The
WPW pattern may occur intermittently and even
disappear over time [3–5].
Although the mechanism is not entirely under-
stood, ventricular pre-excitation is associated with
a higher incidence of AF [6]. A minority of indivi-
duals with both pre-excitation and AF are at some
risk of sudden arrhythmic death, if during AF the
physiological properties of the accessory pathway
allow it to conduct from the atrium to the ventricle
so rapidly that ventricular fibrillation occurs. Atrial
fibrillation will present as an irregular, wide com-
plex tachycardia (each QRS usually with varying
degrees of pre-excitation) at exceedingly fast rates.
In this setting, the shortest interval from one pre-
excited QRS to another may be used to estimate
the risk of sudden death [7].
The degree of pre-excitation may also change
with exercise stress testing. Mulpuru et al. [8]
described a patient with a WPW pattern with
paradoxical septal wall motion on baseline
echocardiography that disappeared along with the
delta wave during peak exercise on treadmill;
both reappeared on recovery. Such a sudden dis-
appearance of pre-excitation during exercise may
indicate poor atrial to ventricular conduction via
the accessory pathway, and so be associated with
a lower risk of sudden death.
Plain treadmill exercise stress test for assess-
ment of ischemia is contraindicated in patients with
WPW pattern, as baseline repolarization changes
preclude accurate assessment of ischemia [9]. Thus,
these patients should undergo stress test with non-
-invasive imaging (echocardiographic or radionu-
clide). The treating team felt that the patient may
not be able to achieve the target heart rate during
treadmill exercise stress test, and ordered a DSE.
Recently, a concern was raised that radionuclide
stress tests are associated with high exposure to
radiation [10, 11]. Therefore, echocardiographic
imaging is usually preferred over radionuclide tests
in our institution.
Figure 3. ECG on recovery with baseline appearance of delta waves.
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Dobutamine is a synthetic b-1 selective cate-
cholamine that increases heart rate, myocardial
contractility, and systolic blood pressure. It is in-
dicated when patients needing non-invasive stress
imaging cannot tolerate (or have contraindications
to) other testing modalities including adenosine or
dipyridamole. Dobutamine has been known to
cause arrhythmias during pharmacological stress
testing such as: premature atrial and ventricular
contractions, atrial fibrillation and flutter, su-
praventricular tachycardias, junctional rhythms,
non-sustained ventricular tachycardia and rate-
related left or right bundle branch blocks [12, 13].
The safety of dobutamine stress testing, and its
value in assessing the risk of sudden death in pa-
tients with pre-excitation, have not been thorough-
ly investigated. However, Molenda et al. [2] stud-
ied 15 patients with intermittent ventricular pre-
excitation and found that dobutamine significantly
shortened the refractory periods, improved acces-
sory pathway conduction, and increased the inci-
dence of arrhythmias.
In our patient, the extent of pre-excitation less-
ened with dobutamine, but the delta waves did not
completely disappear. This was probably, at least in
part, because dobutamine facilitated AV nodal con-
duction and increased the amount of ventricular tis-
sue activated in the normal (His-Purkinje) fashion,
relative to the amount of tissue activated via the ac-
cessory pathway. Theoretically however, the acce-
lerated sinus rate may be approaching the refractory
period of the accessory pathway, thus revealing some
intrinsic property of the latter. If a rate of 150 bpm is
beginning to cause conduction block in the pathway,
then the pathway would probably not conduct rapid-
ly during AF. (The reader is reminded that these pos-
sible scenarios do not take into account the electro-
physiology of atrial tissue between the sinus node
and the accessory pathway, which can also affect the
degree of pre-excitation.)
Whether pharmacological stress testing with
dobutamine is safe in patients with WPW syndrome
has not been established. The sudden loss of pre-
excitation during dobutamine stress testing may not
have the same prognostic implications as it does
when it occurs during exercise stress testing,
where it has been associated with a lower risk of
sudden death. Given the arrhythmic complications
attributed to dobutamine, exercise stress testing
with either echocardiographic or radionuclide ima-
ging would, if possible, be the preferred option for
non-invasive cardiac evaluation in these patients.
However, exercise may also induce arrhythmia.
It has not been studied whether the risk of arrhyth-
mia for patients with WPW is greater with dobu-
tamine than with exercise. During exercise stress
testing, information regarding the patient’s func-
tional capacity would be obtained. This is something
that in itself has prognostic implications, in addition
to assessment of perfusion or regional function.
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